Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$85.18 - $108.78 $422,322 - $539,331
-4,958 Reduced 66.43%
2,506 $270,000
Q1 2024

May 15, 2024

BUY
$73.17 - $99.79 $546,140 - $744,832
7,464 New
7,464 $708,000
Q4 2023

Feb 14, 2024

SELL
$43.96 - $92.84 $263,760 - $557,040
-6,000 Reduced 57.14%
4,500 $415,000
Q3 2023

Nov 14, 2023

BUY
$46.9 - $66.0 $492,450 - $693,000
10,500 New
10,500 $527,000
Q1 2023

May 15, 2023

SELL
$37.97 - $50.0 $864,121 - $1.14 Million
-22,758 Reduced 17.58%
106,693 $4.8 Million
Q4 2022

Feb 14, 2023

BUY
$41.06 - $66.48 $4.99 Million - $8.07 Million
121,440 Added 1515.92%
129,451 $5.67 Million
Q3 2022

Nov 15, 2022

SELL
$49.93 - $77.7 $4.76 Million - $7.4 Million
-95,240 Reduced 92.24%
8,011 $528,000
Q2 2022

Aug 15, 2022

BUY
$45.23 - $70.15 $4.67 Million - $7.24 Million
103,251 New
103,251 $5.15 Million
Q3 2020

Nov 12, 2020

SELL
$66.45 - $92.7 $245,599 - $342,619
-3,696 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$57.09 - $79.27 $331,350 - $460,083
-5,804 Reduced 61.09%
3,696 $288,000
Q1 2020

May 14, 2020

SELL
$48.11 - $82.22 $331,429 - $566,413
-6,889 Reduced 42.03%
9,500 $554,000
Q4 2019

Feb 14, 2020

BUY
$66.73 - $82.59 $1.09 Million - $1.35 Million
16,389 New
16,389 $1.32 Million
Q3 2019

Nov 14, 2019

SELL
$72.9 - $101.41 $911,250 - $1.27 Million
-12,500 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$73.54 - $97.8 $919,250 - $1.22 Million
12,500 New
12,500 $1.21 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $6.18B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.